Peru Profile Updated in ClinRegs
November 23, 2021

The Peru profile in ClinRegs has been reviewed and updated with the following information:

  • Revised or new forms related to clinical trial application, ethics committee accreditation and renewal, clinical trial products and supplies, and request for virtual supervision of a clinical trial (See Forms)
  • New INS communication issued on the updated Peruvian Clinical Trials Registry (Registro Peruano de Ensayos Clínicos (REPEC)) virtual platform, which allows applicants to register new clinical trial procedures, track application authorization status, and monitor active trials (See the Regulatory Authority topic, Clinical Trial Lifecycle topic, and Trial Authorization)
  • New INS communication notifying applicants of the new electronic and in-person procedures to submit clinical trial documentation to the agency’s Document Processing System (See Regulatory Authority and Submission Process)

Sources Added During this Update:

  • (Regulation) Headquarters Resolution No. 064-2021-J-OPE/INS - Approves Procedure for the Application of Sanctions in the Regulatory Framework of Clinical Trials (Res064-2021 - Spanish) (March 23, 2021)
    National Institute of Health, Ministry of Health
  • (Guidance) Procedure for the Application of Sanctions in the Regulatory Framework of Clinical Trials (G-CTSanction - Spanish) (Edition No. 1) (March 23, 2021)
    National Institute of Health, Ministry of Health
  • (Document) Communique No. 001-2021-OGITT/INS - Communication of a New Version of the Peruvian Clinical Trials Registry (REPEC) (PER-88 - Spanish) (January 6, 2021)
    General Office for Research and Technology Transfer, National Institute of Health
  • (Document) Communique No. 003-2021-OGITT/INS - INS Measures for the Receipt of Documents via Virtual and In-Person Delivery Methods (PER-92 - Spanish) (June 2, 2021)
    General Office for Research and Technology Transfer, National Institute of Health
  • (Document) Communique No. 004-2021-OGITT/INS - Sponsor Notification re: Trial Extension Requirements (PER-93 - Spanish) (July 23, 2021)
    General Office for Research and Technology Transfer, National Institute of Health
  • (Document) Multiple Office No. 007-2021-OGITT/INS - General Guidelines for the Approval of Protocols and Informed Consents (PER-82 - Spanish) (May 7, 2021)
    General Office for Research and Technology Transfer, National Institute of Health
  • (Document) Multiple Office No. 014-2021-OGITT/INS - General Guidelines for the Approval of Protocols and Informed Consents - Update (PER-83 - Spanish) (July 9, 2021)
    General Office for Research and Technology Transfer, National Institute of Health
  • (Document) Multiple Office No. 020-2021-OGITT/INS - Endorsement of Research Documents by the Research Ethics Committee - CEI (PER-96 - Spanish) (August 23, 2021)
    General Office for Research and Technology Transfer, National Institute of Health
  • (Document) Preliminary Evaluation Checklist for the Registration of Research Centers (PER-90 - Spanish) (Version 1.0) (March 10, 2011)
    REPEC, National Institute of Health, Ministry of Health
  • (Document) Single Text of Administrative Procedures (TUPA) - Executing Public Agency of the Ministry of Health: National Institute of Health in Compliance with the Supreme Decree No. 062-2009-PCM (PER-97 - Spanish) (Date Unavailable)
    National Institute of Health, Ministry of Health
  • (Form) Virtual Supervision of Clinical Trials (FOR-OGITT-066) (PER-87 - Spanish) (Edition No. 01) (July 26, 2021)
    National Institute of Health, Ministry of Health
  • (Webpage) By Means of a Simple Letter Addressed to the Director General of the General Office for Research and Technology Transfer (OGITT) of the National Institute of Health (PER-95 - Spanish) (Current as of November 22, 2021)
    National Institute of Health, Ministry of Health
  • (Webpage) Peruvian Clinical Trials Registry (REPEC) - Old Registration Platform (PER-91 - Spanish) (Current as of November 22, 2021)
    REPEC, National Institute of Health, Ministry of Health
  • (Webpage) Institutional Research Ethics Committee of the National Institute of Health (CIEI-INS) (PER-94 - Spanish) (Current as of November 22, 2021)
    National Institute of Health, Ministry of Health
  • (Webpage) Peruvian Clinical Trials Registry (REPEC) - Registration Platform (PER-89 - Spanish) (Current as of November 22, 2021)
    REPEC, National Institute of Health, Ministry of Health
  • (Webpage) WHO Trial Registration Data Set (PER-86) (Version 1.3.1) (Current as of November 22, 2021)
    International Clinical Trials Registry Platform (ICTRP), World Health Organization (WHO)

Sources Revised During this Update:

  • (Form) Application for Clinical Trial Authorization (FOR-OGITT-028) (PER-24 - Spanish) (Edition No. 03) (July 23, 2021)
    National Institute of Health, Ministry of Health
  • (Form) List of Products and Supplies to Import in the Clinical Trial (FOR-OGITT-033) (PER-42 - Spanish) (Edition No. 03) (July 26, 2021)
    National Institute of Health, Ministry of Health
  • (Form) Request for Accreditation from the Institutional Ethics Committees (CIEIs) (FOR-OGITT-025) (PER-85 - Spanish) (Edition No. 03) (August 26, 2021)
    National Institute of Health, Ministry of Health
  • (Webpage) Forms, Guides and Annexes (PER-81 - Spanish) (Current as of November 22, 2021)
    National Institute of Health, Ministry of Health
Use the symbols below to refine your search
SymbolExplanation
No symbol At least one of the keywords must be present
Search example: serious adverse event
Result: Will contain serious and/or adverse and/or event
+ Leading plus sign indicates that the word must be present
Search example: serious +adverse event
Result: Will contain adverse and may contain serious and/or event
- Leading minus sign indicates that the word must not be present
Search example: serious adverse -event
Result: Will contain serious and/or adverse but won’t contain event
“ ” Exact phrase must be present
Search example: “serious adverse event”
Result: Will contain the phrase serious adverse event
Call for online focus group participants!
x

ClinRegs content is published in English. ClinRegs offers translations of the content through Google Translate, which is an external translation service. ClinRegs does not control the quality or accuracy of translated content and may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages.